<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35088199</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2576</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Inflammation</Title><ISOAbbreviation>Inflammation</ISOAbbreviation></Journal><ArticleTitle>Knockdown of LncRNA MALAT1 Alleviates Coxsackievirus B3-Induced Acute Viral Myocarditis in Mice via Inhibiting Th17 Cells Differentiation.</ArticleTitle><Pagination><StartPage>1186</StartPage><EndPage>1198</EndPage><MedlinePgn>1186-1198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10753-021-01612-x</ELocationID><Abstract><AbstractText>Acute viral myocarditis (AVMC), most often caused by coxsackievirus B3 (CVB3) infection, is characterized by myocardial inflammation associated with high morbidity and mortality. A pathogenic role for T helper (Th) 17 cells in AVMC is well established.&#xa0;Long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been shown to play a key role in various inflammatory diseases. However, the expression of MALAT1 and its impact on Th17 cells differentiation in AVMC remain unclear. In the present study, we found that MALAT1 was highly expressed in mice with AVMC, and the expression was correlated positively with cardiac pathological scores, cardiac IL-17 mRNA expression, and the percentages of splenic Th17 cells. We further demonstrated that MALAT1 knockdown could significantly alleviate the severity of disease and inhibit the differentiation of Th17 cells, accompanying the reduced mRNA expression of ROR&#x3b3;t and productions of Th17-related pro-inflammatory cytokines in vivo. Additionally, in vitro analysis showed that MALAT1 knockdown suppressed na&#xef;ve CD4<sup>+</sup> T cells differentiation towards Th17 cells. In conclusion, our results suggest that MALAT1 knockdown alleviates CVB3-induced AVMC in mice, which may be partially attributable to the decline in Th17 cells responses. MALAT1 may serve as a novel therapeutic option in AVMC.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yimin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Fourth Department of Intensive Care Unit, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiaofen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Fourth Department of Intensive Care Unit, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Fourth Department of Intensive Care Unit, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mingguang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Fourth Department of Intensive Care Unit, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Tingfeng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Fourth Department of Intensive Care Unit, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Fenghui</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Fourth Department of Intensive Care Unit, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Feng</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4419-9707</Identifier><AffiliationInfo><Affiliation>Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, Fujian, People's Republic of China. fjslchenfeng@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency, Fujian Provincial Hospital, Fuzhou, 350001, Fujian, People's Republic of China. fjslchenfeng@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, People's Republic of China. fjslchenfeng@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018QH1120</GrantID><Agency>the Startup Fund for Scientific Research of Fujian Medical University</Agency><Country/></Grant><Grant><GrantID>2019-2-1</GrantID><Agency>the Youth Scientific Research Project of Fujian Provincial Health Commission</Agency><Country/></Grant><Grant><GrantID>2020HSJJ12</GrantID><Agency>2020 High-level Hospital Foster Grants from Fujian Provincial Hospital of Fujian Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Inflammation</MedlineTA><NlmUniqueID>7600105</NlmUniqueID><ISSNLinking>0360-3997</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058504" MajorTopicYN="N">Th17 Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MALAT1</Keyword><Keyword MajorTopicYN="N">Th17 cells</Keyword><Keyword MajorTopicYN="N">acute viral myocarditis</Keyword><Keyword MajorTopicYN="N">differentiation.</Keyword><Keyword MajorTopicYN="N">long noncoding RNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>28</Day><Hour>5</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35088199</ArticleId><ArticleId IdType="doi">10.1007/s10753-021-01612-x</ArticleId><ArticleId IdType="pii">10.1007/s10753-021-01612-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pankuweit, S., and K. Klingel. 2013. Viral myocarditis: From experimental models to molecular diagnosis in patients. Heart Failure Reviews 18 (6): 683&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-012-9357-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather, D., K.A. Stafford, and Y.K. Sung. 2012. Update on coxsackievirus B3 myocarditis. Current Opinion in Rheumatology 24 (4): 401&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328353372d</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracamonte-Baran, W., and D. &#x10c;ih&#xe1;kov&#xe1;. 2017. Cardiac autoimmunity: Myocarditis. Advances in Experimental Medicine and Biology 1003: 187&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-57613-8_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda, K., Y. Takeuchi, and K. Hirota. 2019. The pathogenicity of Th17 cells in autoimmune diseases. Seminars in Immunopathology 41 (3): 283&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-019-00733-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, J., A.L. Cao, M. Yu, Q.W. Lin, X. Yu, J.H. Zhang, M. Wang, H.P. Guo, and Y.H. Liao. 2010. Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis. Journal of Clinical Immunology 30 (2): 226&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-009-9355-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, H., and X. Guo. 2016. Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance. Virology Journal 13 (1): 168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0626-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, L., L. Li, L. Xiao, and J. Shangguan. 2018. Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells. Experimental Cell Research 367 (2): 241&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.04.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Thum, T., and G. Condorelli. 2015. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circulation Research 116 (4): 751&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.303549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponting, C.P., P.L. Oliver, and W. Reik. 2009. Evolution and functions of long noncoding RNAs. Cell 136 (4): 629&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornienko, A.E., P.M. Guenzl, D.P. Barlow, and F.M. Pauler. 2013. Gene regulation by the act of long non-coding RNA transcription. BMC Biology 11: 59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7007-11-59</ArticleId></ArticleIdList></Reference><Reference><Citation>Shui, X., S. Chen, J. Lin, J. Kong, C. Zhou, and J. Wu. 2019. Knockdown of lncRNA NEAT1 inhibits Th17/CD4<sup>+</sup> T cell differentiation through reducing the STAT3 protein level. Journal of Cellular Physiology 234 (12): 22477&#x2013;22484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28811</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, F., G. Liu, D. Li, C. Wei, and J. Hao. 2018. DDIT4 and associated lncDDIT4 modulate Th17 differentiation through the DDIT4/TSC/mTOR pathway. Journal of Immunology (Baltimore Md: 1950) 200 (5): 1618&#x2013;1626.</Citation></Reference><Reference><Citation>Zhang, Y., X. Li, C. Wang, M. Zhang, H. Yang, and K. Lv. 2020. lncRNA AK085865 promotes macrophage M2 polarization in CVB3-induced VM by regulating ILF2-ILF3 complex-mediated miRNA-192 biogenesis. Molecular Therapy Nucleic Acids 21: 441&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2020.06.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue, Y.L., S.X. Zhang, C.F. Zheng, Y.F. Li, L.H. Zhang, Q.Y. Su, Y.F. Hao, S. Wang, and X.W. Li. 2020. Long non-coding RNA MEG3 inhibits M2 macrophage polarization by activating TRAF6 via microRNA-223 down-regulation in viral myocarditis. Journal of Cellular and Molecular Medicine 24 (21): 12341&#x2013;12354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, H., B. Yang, Y. Zhao, X. Deng, and X. Shen. 2020. The pro-apoptosis and pro-inflammation role of LncRNA HIF1A-AS1 in coxsackievirus B3-induced myocarditis via targeting miR-138. Cardiovascular Diagnosis and Therapy 10 (5): 1245&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt-20-545</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, W., L. Chen, L. Chen, and Q. Kou. 2020. Silencing of long non-coding RNA MALAT1 suppresses inflammation in septic mice: Role of microRNA-23a in the down-regulation of MCEMP1 expression. Inflammation Research 69 (2): 179&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-019-01306-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., F. Wang, G. Chen, R. He, and L. Yang. 2019. LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis. Cell and Bioscience 9: 54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-019-0302-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardamone, G., E.M. Paraboschi, G. Sold&#xe0;, C. Cantoni, D. Supino, L. Piccio, S. Duga, and R. Asselta. 2019. Not only cancer: The long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis. Human Molecular Genetics 28 (9): 1414&#x2013;1428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy438</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoumi, F., S. Ghorbani, F. Talebi, W.G. Branton, S. Rajaei, C. Power, and F. Noorbakhsh. 2019. Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 328: 50&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2018.11.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, Z., and F. Tang. 2020. The potency of lncRNA MALAT1/miR-155/CTLA4 axis in altering Th1/Th2 balance of asthma. Bioscience Reports 40 (2): BSR20190397.</Citation></Reference><Reference><Citation>Yao, Y., W. Guo, J. Chen, P. Guo, G. Yu, J. Liu, F. Wang, J. Liu, M. You, T. Zhao, Y. Kang, X. Ma, and S. Yu. 2018. Long noncoding RNA Malat1 is not essential for T cell development and response to LCMV infection. RNA Biology 15 (12): 1477&#x2013;1486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2018.1551705</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabie, N., M.W. Delfs, J.R. Westrich, V.A. Love, G. Stavrakis, F. Ahmad, C.E. Seidman, J.G. Seidman, and A.H. Lichtman. 2003. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. The Journal of Clinical Investigation 111 (5): 671&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200316867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji, P., S. Diederichs, W. Wang, S. B&#xf6;ing, R. Metzger, P.M. Schneider, N. Tidow, B. Brandt, H. Buerger, E. Bulk, M. Thomas, W.E. Berdel, H. Serve, and C. M&#xfc;ller-Tidow. 2003. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22 (39): 8031&#x2013;8041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1206928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding, Y., F. Guo, T. Zhu, J. Li, D. Gu, W. Jiang, Y. Lu, and D. Zhou. 2018. Mechanism of long non-coding RNA MALAT1 in lipopolysaccharide-induced acute kidney injury is mediated by the miR-146a/NF-&#x3ba;B signaling pathway. International Journal of Molecular Medicine 41 (1): 446&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">29115409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan, C.C., N. Zhang, K. Cheung, H.D. Zhang, W. Li, C.Y. Hong, H.S. Chen, X.Y. Liu, N. Li, and L. Cheng. 2020. Knockdown of lncRNA MALAT1 alleviates LPS-induced acute lung injury via inhibiting apoptosis through the miR-194&#x2013;5p/FOXP2 axis. Frontiers in Cell and Developmental Biology 8: 586869.</Citation></Reference><Reference><Citation>Gu, H., Y. Zhu, Y. Zhou, T. Huang, S. Zhang, D. Zhao, and F. Liu. 2020. LncRNA MALAT1 affects mycoplasma pneumoniae pneumonia via NF-&#x3ba;B regulation. Frontiers in Cell and Developmental Biology 8: 563693.</Citation></Reference><Reference><Citation>Yao, M.Y., W.H. Zhang, W.T. Ma, Q.H. Liu, L.H. Xing, and G.F. Zhao. 2020. Long non-coding RNA MALAT1 exacerbates acute respiratory distress syndrome by upregulating ICAM-1 expression via microRNA-150-5p downregulation. Aging 12 (8): 6570&#x2013;6585.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102953</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremer, S., K.M. Michalik, A. Fischer, L. Pfisterer, N. Ja&#xe9;, C. Winter, R.A. Boon, M. Muhly-Reinholz, D. John, S. Uchida, C. Weber, W. Poller, S. G&#xfc;nther, T. Braun, D.Y. Li, L. Maegdefessel, L. Perisic Matic, U. Hedin, O. Soehnlein, A. Zeiher, and S. Dimmeler. 2019. Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation. Circulation 139 (10): 1320&#x2013;1334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.029015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M., H. Gu, W. Xu, and X. Zhou. 2016. Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats. International Journal of Cardiology 203: 214&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.10.136</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia, P., N. Wu, D. Jia, and Y. Sun. 2019. Downregulation of MALAT1 alleviates saturated fatty acid-induced myocardial inflammatory injury via the miR-26a/HMGB1/TLR4/NF-&#x3ba;B axis. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 12: 655&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S203151</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, K.M., and B. Stockinger. 2010. Effector T cell plasticity: Flexibility in the face of changing circumstances. Nature Immunology 11 (8): 674&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura, A., and T. Kishimoto. 2011. Th17 cells in inflammation. International Immunopharmacology 11 (3): 319&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2010.10.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitson, J.P., K.A. West, K.R. James, G.F. Rani, N. Dey, A. Romano, N. Brown, S.A. Teichmann, P.M. Kaye, and D. Lagos. 2020. Malat1 suppresses immunity to infection through promoting expression of Maf and IL-10 in Th cells. Journal of Immunology (Baltimore Md: 1950) 204 (11): 2949&#x2013;2960.</Citation></Reference><Reference><Citation>Cui, H., S. Banerjee, S. Guo, N. Xie, J. Ge, D. Jiang, M. Z&#xf6;rnig, V.J. Thannickal, and G. Liu. 2019. Long noncoding RNA Malat1 regulates differential activation of macrophages and response to lung injury. JCI Insight 4 (4): e124522.</Citation></Reference><Reference><Citation>Liu, W., Z. Wang, L. Liu, Z. Yang, S. Liu, Z. Ma, Y. Liu, Y. Ma, L. Zhang, X. Zhang, M. Jiang, and X. Cao. 2020. LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity. Proceedings of the National Academy of Sciences of the United States of America 117 (38): 23695&#x2013;23706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003932117</ArticleId></ArticleIdList></Reference><Reference><Citation>Isono, F., S. Fujita-Sato, and S. Ito. 2014. Inhibiting ROR&#x3b3;t/Th17 axis for autoimmune disorders. Drug Discovery Today 19 (8): 1205&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2014.04.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S., Y. Sun, L. Zhong, Z. Xiao, M. Yang, M. Chen, C. Wang, X. Xie, and X. Chen. 2018. The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway. Nutrition Metabolism and Cardiovascular Diseases: NMCD 28 (11): 1175&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2018.06.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Q., Q. Run, C.Y. Li, X.Y. Xiong, and X.L. Wu. 2020. LncRNA MALAT1 promotes STAT3-mediated endothelial inflammation by counteracting the function of miR-590. Cytogenetic and Genome Research 160 (10): 565&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509811</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, L., F. Hu, X. Yan, Y. Wei, W. Ma, Y. Wang, S. Lu, and Z. Wang. 2016. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response. Journal of Molecular Medicine (Berlin Germany) 94 (9): 1063&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-016-1414-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, D., M. Tang, P. Zong, H. Liu, T. Zhang, Y. Liu, and Y. Zhao. 2018. MiRNA-155 regulates the Th17/Treg ratio by targeting SOCS1 in severe acute pancreatitis. Frontiers in Physiology 9: 686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>